Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial.

MLA

Pittayanon, Rapat, et al. “Cytoprotective Agent for Peptic Ulcer Prevention in Patients Taking Dual Antiplatelet Agents: A Randomized, Double-Blind Placebo-Controlled Trial.” Journal of Gastroenterology and Hepatology, vol. 34, no. 9, Sept. 2019, pp. 1517–22. EBSCOhost, https://doi.org/10.1111/jgh.14671.

APA

Pittayanon, R., Piyachaturawat, P., Rerknimitr, R., Prueksapanich, P., Chaitongrat, S., Lertsuwunseri, V., Srimahachota, S., & Mahachai, V. (2019). Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial. Journal of Gastroenterology and Hepatology, 34(9), 1517–1522. https://doi.org/10.1111/jgh.14671

Chicago

Pittayanon, Rapat, Panida Piyachaturawat, Rungsun Rerknimitr, Piyapan Prueksapanich, Supakarn Chaitongrat, Vorarit Lertsuwunseri, Suphot Srimahachota, and Varocha Mahachai. 2019. “Cytoprotective Agent for Peptic Ulcer Prevention in Patients Taking Dual Antiplatelet Agents: A Randomized, Double-Blind Placebo-Controlled Trial.” Journal of Gastroenterology and Hepatology 34 (9): 1517–22. doi:10.1111/jgh.14671.